Monday, 27 April 2009

Cidine




Cidine may be available in the countries listed below.


Ingredient matches for Cidine



Cimetidine

Cimetidine is reported as an ingredient of Cidine in the following countries:


  • Thailand

Cinitapride

Cinitapride tartrate (a derivative of Cinitapride) is reported as an ingredient of Cidine in the following countries:


  • Spain

International Drug Name Search

Amikozit




Amikozit may be available in the countries listed below.


Ingredient matches for Amikozit



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amikozit in the following countries:


  • Romania

  • Turkey

  • Yemen

International Drug Name Search

Wednesday, 22 April 2009

Grifoparkin




Grifoparkin may be available in the countries listed below.


Ingredient matches for Grifoparkin



Carbidopa

Carbidopa is reported as an ingredient of Grifoparkin in the following countries:


  • Peru

Levodopa

Levodopa is reported as an ingredient of Grifoparkin in the following countries:


  • Peru

International Drug Name Search

Sunday, 19 April 2009

Noradrénaline Mylan




Noradrénaline Mylan may be available in the countries listed below.


Ingredient matches for Noradrénaline Mylan



Norepinephrine

Norepinephrine tartrate (a derivative of Norepinephrine) is reported as an ingredient of Noradrénaline Mylan in the following countries:


  • France

International Drug Name Search

Tuesday, 14 April 2009

Wamag




Wamag may be available in the countries listed below.


Ingredient matches for Wamag



Calcium

Calcium mixture of several salts (a derivative of Calcium) is reported as an ingredient of Wamag in the following countries:


  • Poland

Magnesium Lactate

Magnesium Lactate is reported as an ingredient of Wamag in the following countries:


  • Poland

International Drug Name Search

Sunday, 12 April 2009

Chanoprim




Chanoprim may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Chanoprim



Sulfadiazine

Sulfadiazine is reported as an ingredient of Chanoprim in the following countries:


  • Ireland

  • United Kingdom

Trimethoprim

Trimethoprim is reported as an ingredient of Chanoprim in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Thursday, 9 April 2009

Mitomycine




Mitomycine may be available in the countries listed below.


Ingredient matches for Mitomycine



Mitomycin

Mitomycine (DCF) is known as Mitomycin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Fosinil




Fosinil may be available in the countries listed below.


Ingredient matches for Fosinil



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Fosinil in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Wednesday, 8 April 2009

Newace




Newace may be available in the countries listed below.


Ingredient matches for Newace



Fosinopril

Fosinopril sodium salt (a derivative of Fosinopril) is reported as an ingredient of Newace in the following countries:


  • Netherlands

International Drug Name Search

Buventol Easyhaler




Buventol Easyhaler may be available in the countries listed below.


Ingredient matches for Buventol Easyhaler



Salbutamol

Salbutamol is reported as an ingredient of Buventol Easyhaler in the following countries:


  • Poland

  • Thailand

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Buventol Easyhaler in the following countries:


  • Austria

  • Czech Republic

  • Denmark

  • Estonia

  • Hungary

  • Latvia

  • Malaysia

  • Norway

  • Singapore

  • Sweden

International Drug Name Search

Tuesday, 7 April 2009

Undex




Undex may be available in the countries listed below.


Ingredient matches for Undex



Clotrimazole

Clotrimazole is reported as an ingredient of Undex in the following countries:


  • Switzerland

International Drug Name Search

Monday, 6 April 2009

Buscopan Inject




Buscopan Inject may be available in the countries listed below.


Ingredient matches for Buscopan Inject



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Buscopan Inject in the following countries:


  • Switzerland

International Drug Name Search

Elcid




Elcid may be available in the countries listed below.


Ingredient matches for Elcid



Clotrimazole

Clotrimazole is reported as an ingredient of Elcid in the following countries:


  • Japan

International Drug Name Search

Sunday, 5 April 2009

Lamictal XR


See also: Generic Lamictal, Generic Lamictal CD, Generic Lamictal ODT


Lamictal XR is a brand name of lamotrigine, approved by the FDA in the following formulation(s):


LAMICTAL XR (lamotrigine - tablet, extended release; oral)



  • Manufacturer: SMITHKLINE BEECHAM

    Approval date: May 29, 2009

    Strength(s): 100MG, 200MG, 25MG, 50MG [RLD]


  • Manufacturer: SMITHKLINE BEECHAM

    Approval date: April 14, 2010

    Strength(s): 300MG


  • Manufacturer: SMITHKLINE BEECHAM

    Approval date: June 21, 2011

    Strength(s): 250MG

Has a generic version of Lamictal XR been approved?


No. There is currently no therapeutically equivalent version of Lamictal XR available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lamictal XR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Lamictal XR.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • May 29, 2012 - NEW DOSAGE FORM

    • November 29, 2012 - PEDIATRIC EXCLUSIVITY

    • January 29, 2013 - ADJUNCTIVE THERAPY FOR PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN PATIENTS THIRTEEN YEARS OF AGE AND OLDER

    • April 15, 2014 - MONOTHERAPY IN PATIENTS 13 YEARS OF AGE AND OLDER WITH PARTIAL SEIZURES WHO ARE RECEIVING THERAPY WITH A SINGLE ANTIEPILEPTIC DRUG (AED)

    • April 25, 2014 - MONOTHERAPY IN PATIENTS 13 YEARS OF AGE AND OLDER WITH PARTIAL SEIZURES WHO ARE RECEIVING THERAPY WITH A SINGLE ANTIEPILEPTIC DRUG (AED)

See also...

  • Lamictal XR Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Lamictal XR Consumer Information (Cerner Multum)
  • Lamictal XR Patient Titration Kit (Blue) Consumer Information (Cerner Multum)
  • Lamictal XR Patient Titration Kit (Green) Consumer Information (Cerner Multum)
  • Lamictal XR Patient Titration Kit (Orange) Consumer Information (Cerner Multum)
  • Lamictal XR Advanced Consumer Information (Micromedex)
  • Lamotrigine Consumer Information (Wolters Kluwer)
  • Lamotrigine Chewable Dispersible Tablets Consumer Information (Wolters Kluwer)
  • Lamotrigine Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Lamotrigine Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
  • Lamotrigine Consumer Information (Cerner Multum)
  • Lamotrigine Advanced Consumer Information (Micromedex)
  • Lamotrigine AHFS DI Monographs (ASHP)

Thursday, 2 April 2009

Aprovel




Aprovel may be available in the countries listed below.


UK matches:

  • Aprovel 75 mg tablets, Aprovel 150 mg tablets, Aprovel 300 mg tablets (SPC)
  • Aprovel 75 mg, 150 mg and 300 mg Film-Coated Tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (SPC)
  • Aprovel Film-Coated Tablets (sanofi-aventis) (SPC)
  • Aprovel Film-Coated Tablets (sanofi-aventis Bristol-Myers Squibb SNC) (SPC)

Ingredient matches for Aprovel



Irbesartan

Irbesartan is reported as an ingredient of Aprovel in the following countries:


  • Antigua & Barbuda

  • Argentina

  • Aruba

  • Bahamas

  • Bahrain

  • Belgium

  • Belize

  • Bermuda

  • Brazil

  • Bulgaria

  • Cayman Islands

  • Chile

  • China

  • Colombia

  • Costa Rica

  • Croatia (Hrvatska)

  • Denmark

  • Dominican Republic

  • Ecuador

  • El Salvador

  • France

  • Germany

  • Greece

  • Guatemala

  • Haiti

  • Honduras

  • Hong Kong

  • Hungary

  • Iceland

  • Indonesia

  • Ireland

  • Italy

  • Jamaica

  • Luxembourg

  • Malaysia

  • Mexico

  • Myanmar

  • Netherlands

  • Netherlands Antilles

  • Nicaragua

  • Norway

  • Oman

  • Panama

  • Peru

  • Philippines

  • Portugal

  • Romania

  • Russian Federation

  • Saint Lucia

  • Saint Vincent & The Grenadines

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Trinidad & Tobago

  • Tunisia

  • United Kingdom

  • Venezuela

  • Vietnam

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 1 April 2009

Dogminth




Dogminth may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dogminth



Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Dogminth in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search